Form 4 for COR Cencora

Accepted 2022-05-13 00:00:00 ET · period of report 2022-05-11 · accession 0000899243-22-018024 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
I	2022-05-13	2022-05-11	COR	Walgreens Boots Alliance, Inc.	10%	S - Sale	$150.00	-6.00M	52.85M	-10%	-$900.00M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-05-11	S	D	6,000,000	$150.00	52,854,867	I See footnotes	—	—	(F1) As previously disclosed, including in the Schedule 13D filed by Walgreen Co. ("Walgreens") and others on April 15, 2014, as amended on January 16, 2015, January 25, 2016, March 22, 2016, August 25, 2016, November 4, 2016, January 6, 2021, June 3, 2021 and May 12, 2022, the Form 8-K filed by the Issuer on March 20, 2013, the Form 8-K filed by Walgreens on March 20, 2013, the Form 8-K filed by Walgreens on June 4, 2021 and the Form 8-K filed by the Issuer on June 2, 2021, the shares referenced in this Form 4 were acquired in accordance with the Framework Agreement, dated as of March 18, 2013 among Walgreens, Alliance Boots GmbH and the Issuer (the "Framework Agreement") and include 2,000,000 shares acquired pursuant to the consummation of the transactions contemplated by the Share Purchase Agreement, dated as of January 6, 2021 (the "SPA"), by and between the Reporting Person and the Issuer. (F3) As described in the Schedule 13D, as amended, WBA Investments, Inc., a direct wholly-owned subsidiary of the Reporting Person and the sole member of WBA Holdings, may also be deemed to beneficially own the securities reported in this Form 4. (F2) These shares were held by Walgreens Boots Alliance Holdings LLC ("WBA Holdings"), an indirect wholly owned subsidiary of the Reporting Person.